Author - Brigitte Ganter

When “Anonymous” Isn’t: The UK Biobank Data Exposure and the Limits of Health Data Privacy

From Surveys to Signals: How AI Is Changing Voice of the Customer in Life Sciences

From Experimentation to Execution: How 2025 Reset the Trajectory of Healthcare and What 2026 Will Demand

Tempus Scoops Up OneOme’s Pharmacogenetics Assets as Precision Medicine Shakeout Continues

Stop Guessing. Start Diagnosing: The Marketing & Product-Market Fit Scorecard

BEVIMI Launches: A New Bid to Bring Pharma-Grade Rigor to Brain Health

Strong Grip, Strong Future: A Key Predictor of Healthy Aging

Most Life Science Startups Hire Too Small. Here’s Why That’s a Costly Mistake

Germany Calls for a Policy Shift to Address their Country’s Aging Population

Dozens of states sue to block the sale of 23andMe personal genetic data without customer consent

Voice of the Customer (VoC) Programs Are a Must Have

A Look at Human Longevity & Life Expectancy

Cloud for AI/ML & Modern Data Science

AGBT 2025 – And the Winner is, Drum Roll, Sequencing

Velsera Is Building an Ecosystem that Accelerates the R&D Loop and Democratizes Omics Data to Propel the Next Era of Precision Medicine

The Cheap Genome Is Not Enough – We Need an “Accurate and Good Genome”

Copyright © 2026. enlighenbio LLC. All rights reserved.